Cryobank
Donor Database
Egg donation
Vitrification (Flash Freezing) Explained: Why Frozen Donor-Egg Embryo Transfers Are So Successful Today
Ten years ago, frozen embryo transfer (FET) was widely feared: freezing was believed to damage embryos, lower pregnancy rates, and serve only as a backup when fresh transfer wasn’t possible. Patients were told frozen embryos worked “almost as well,” implying inferiority. Today that view is obsolete. At NGC Clinic, over 85% of donor egg transfers are FET—not due to limitations of fresh cycles, but because frozen transfers now deliver equal or better outcomes while offering advantages fresh protocols simply can’t match.
This shift was driven by one breakthrough: vitrification. Replacing outdated slow-freeze methods, this ultra-rapid “flash freezing” achieves blastocyst survival rates above 97%, meaning nearly every embryo that reaches vitrification also survives warming. Large-scale studies now show pregnancy rates with frozen transfers match or exceed fresh transfers—an unthinkable result a decade ago [1][2]. For international patients undergoing donor egg cycles with PGT-A, this isn’t theoretical: your embryos will be frozen, and your success depends on how well they survive the freeze-thaw process.
1983-2000: The slow-freeze era
The first successful pregnancy from a frozen human embryo occurred in 1983, using "controlled slow freezing"—the same technology used to preserve other biological tissues [3].
The slow-freeze protocol:
- Embryos immersed in cryoprotectant solution (typically DMSO - dimethyl sulphoxide)
- Temperature decreased gradually: ~2°C per minute
- Ice formation initiated at -7°C (controlled seeding)
- Continued cooling to -30°C to -40°C
- Final transfer to liquid nitrogen storage (-196°C)
- Total process: 2-3 hours
The problem: Even with cryoprotectants, slow cooling allows time for ice crystals to form both outside and inside cells. These crystals physically damage cellular membranes, disrupt organelles, and cause cell death.
Slow-freeze embryo outcomes (1980s-1990s data):
- Survival rate (all blastomeres intact): 60-70%
- Survival rate (≥50% blastomeres intact): 75-85%
- Pregnancy rate per transfer: 15-25% (vs. 25-35% for fresh transfers)
Slow-freezing worked—barely. It allowed embryo banking and prevented the ethical dilemma of discarding viable embryos. But significant embryo damage occurred, and patients rightfully viewed frozen transfer as inferior to fresh.
1985-1998: The vitrification concept emerges
Cryobiologists recognized a theoretical solution: if cooling occurred fast enough, water molecules would transition directly to a solid "glass-like" state (vitrification) without forming ice crystals.
The challenge: achieving cooling rates of ~-23,000°C per minute—over 10,000x faster than slow-freeze protocols [4].
Early attempts used:
- Very small volumes (microliters)
- Extremely high cryoprotectant concentrations (potentially toxic)
- Direct immersion in liquid nitrogen
Results were promising but technically difficult, requiring specialized equipment and expertise beyond most IVF laboratories' capabilities.
2000-2010: Vitrification becomes clinically viable
Two key innovations made vitrification practical:
Innovation 1: Carrier systems
- Cryotop™ (2005): Ultra-thin strip allowing minimal fluid volume
- Cryolock™ and similar devices: Protected vitrification with controlled minimal volume
- These devices enabled reliable ultra-rapid cooling without specialized equipment
Innovation 2: Optimized cryoprotectant cocktails
- Ethylene glycol + DMSO combinations
- Sucrose addition (draws water out of cells before vitrification)
- Sequential exposure protocols (gradual equilibration, then rapid vitrification)
By 2008-2010, multiple randomized trials demonstrated vitrification's superiority. The evidence was overwhelming.
2010-present: Vitrification becomes the global standard
Today, vitrification represents >95% of embryo cryopreservation in advanced fertility centers. Slow-freezing persists only in laboratories lacking updated equipment or in countries where regulations haven't adapted to modern technology.
Step 1: Gentle Preparation (5–15 minutes)
Before freezing, embryos are placed in a mild protective solution containing cryoprotectants (special compounds that shield cells during freezing). This step allows the protectants to gradually enter the cells and replace some water—slowly enough to avoid shock from sudden fluid shifts.
Step 2: Final Protection (Under 60 seconds)
The embryo moves briefly into a stronger protective solution with higher concentrations of cryoprotectants. A sugar (sucrose) in this solution gently draws extra water out of the cells, helping prevent ice formation later.
Timing is critical: This solution can become harmful if exposure lasts too long, so embryologists work quickly—typically completing this step in under one minute.
Step 3: Ultra-Fast Loading (Under 10 seconds)
Using a fine tool, the embryologist places the embryo onto a tiny carrier strip (such as the widely used Cryotop® device) in a droplet smaller than a grain of sand. Excess fluid is carefully blotted away—because smaller volumes freeze faster and more safely.
Step 4: Instant Freezing (Less than 1 second)
The carrier is plunged directly into liquid nitrogen at –196°C (–321°F). The temperature plummets at roughly 23,000°C per minute—so fast that water molecules freeze instantly without time to form sharp ice crystals. Instead, they lock into a smooth, glass-like state. You'll see a brief burst of bubbles as the liquid nitrogen flashes into vapor—a sign the process is complete.
Step 5: Long-Term Storage
Vitrified embryos are sealed in labeled containers and stored submerged in liquid nitrogen tanks. They remain in suspended animation with no biological activity.
Storage success: Healthy babies have been born from embryos stored for 30 years (the current verified record, 2022). While research continues on very long-term storage effects, vitrification has proven remarkably stable—enabling families to preserve embryos for future use with high confidence.
Why this matters: By avoiding ice crystals—the main cause of cell damage in older freezing methods—vitrification has dramatically improved survival rates after thawing, making frozen embryo transfers nearly as successful as fresh ones in modern IVF.
Study 1: No difference between short vs. long storage
Analysis of 1,283 vitrified blastocyst transfers:
- Storage <1 year: 57.2% pregnancy rate
- Storage 1-5 years: 56.8% pregnancy rate
- Storage >5 years: 58.1% pregnancy rate
- p = 0.89 (no significant difference) [13]
Study 2: Longest documented successful storage
27-year storage (embryo frozen 1992, transferred 2020):
- Embryo survival: Yes
- Pregnancy: Yes
- Live birth: Healthy baby, no complications
- Conclusion: Even multi-decade storage produces normal outcomes [6]
Requirement 1: PGT-A turnaround time
Trophectoderm biopsy → NGS analysis → Results: 10-14 days minimum
During this time, embryos MUST be vitrified. Fresh transfer is logistically impossible when genetic testing is performed.
Requirement 2: International travel logistics
FET timeline:
- Trip 1 (Retrieval): 2-3 days total (leave immediately after biopsy/vitrification)
- Return home while PGT-A processed
- Trip 2 (Transfer): 4-5 days (arrive for lining check → transfer → depart)
- Total stay: 6-8 days across TWO trips
The FET protocol saves a considerable number of days of international stay while providing superior outcomes.
Requirement 3: Optimal embryo selection
Fresh transfer (if PGT-A not done):
- Transfer embryo on Day 5 based solely on morphology
- Unknown if embryo is euploid
- Remaining embryos still developing (can't assess full cohort)
FET after PGT-A:
- Know exactly how many euploid embryos you have
- Transfer highest-quality euploid first
- Preserve remaining euploids for future children
- Avoid wasting time/money on aneuploid transfers
Concern 1: "Won't freezing damage my embryos?"
With modern vitrification: No. Survival rates exceed 97% for blastocysts. The 2-3% that don't survive typically had underlying quality issues making them non-viable regardless of freezing.
Data reassurance: 98.1% of NGC vitrified blastocysts survive warming. This is equivalent to saying "freezing causes no damage in 98 of 100 embryos."
Concern 2: "Are frozen embryos less likely to implant than fresh?"
No. Large-scale studies show FET produces pregnancy rates equal to or slightly higher than fresh transfer, especially when combined with PGT-A.
Your specific situation (donor eggs + PGT-A): FET with euploid embryo achieves 60-65% live birth rate—superior to fresh transfer without genetic testing (53-58% live birth rate).
Concern 3: "Will my baby be healthy if conceived from a frozen embryo?"
Yes. Extensive neonatal outcome studies show babies born from FET have:
- Normal birth weights (actually slightly higher average than fresh transfer babies)
- Normal developmental milestones
- No increased rate of congenital abnormalities
- Some studies suggest LOWER rates of preterm birth and low birth weight compared to fresh transfers [14]
Long-term follow-up: Children conceived from frozen embryos tracked through adolescence show normal cognitive development, physical health, and no increased medical conditions [15].
Concern 4: "Can I choose exactly when to transfer, or am I on the clinic's schedule?"
FET provides scheduling flexibility impossible with fresh transfer:
✓ You choose transfer month (plan around work, travel, life events) ✓ Clinic books transfer date 4-8 weeks in advance (predictable timing)
✓ If you get sick or need to postpone, embryos remain safely frozen—reschedule when ready ✓ No urgency or "use it or lose it" pressure
This flexibility is especially valuable for international patients coordinating travel, work leave, childcare for existing children, etc.
The scientific supervisor reviewed the article
Lobzeva Diana
Make an appointment
